Partnerships In Clinical Trials Expands Its Global Reach

The Institute for International Research is pleased to announce that as a chief component of its global branding strategy, the industry-leading Partnerships with CROs event is now known as Partnerships in Clinical Trials. In the nineteen years since the inception of the event, both the biopharmaceutical industry and Partnerships have experienced tremendous growth as outsourcing to suppliers has become more than simply a tactic to control costs, but a leading strategic directive to ensure speed, quality and value of new medicines. “The name Partnerships in Clinical Trials reflects the comprehensive nature of the program, which is the must-attend annual event for clinical outsourcing and development professionals and is increasingly valuable to those with responsibilities in clinical operations, clinical project management, drug safety and quality,” said program director Lesly Atlas. “Our new name also represents our widening global reach with Partnerships in Clinical Trials events already taking place in Europe and the premier of our APAC event in Singapore this December. Collectively the Partnerships in Clinical Trials brand serves over 35 countries.”

Notable speakers include:

• Tom Daschle, Former Senate Majority and Minority Leader, US Senate
• David Holveck, President and CEO, Endo Pharmaceuticals
• Nancy Simonian, MD, Chief Medical Officer and Senior Vice President of Clinical, Medical, and Regulatory Affairs, Millennium: The Takeda Oncology Company
• Ethan Zohn, Winner of Survivor: Africa Chris Anderson, Editor-in-Chief, Wired Magazine and NYT Bestselling Author, The Long Tail: Why the Future of Business is Selling Less of More
• Thomas Senderovitz, MD, Vice President, Global Exploratory Development, UCB Pharma - Belgium
• Jason Hwang, MD, Executive Director, Innosight Institute
• Deirdre BeVard, Vice President, Clinical Operations and Data Management, Endo Pharmaceuticals
• Reinilde Heyrman, Vice President, Clinical Development and Operations, Daiichi Sankyo Pharma Development
• Peter Carberry, Senior Vice President, Global Development Operations, Astellas Pharmaceuticals
• Kenneth Getz, Senior Research Fellow, Tufts Center for the Study of Drug Development
• John Balian, MD, Senior Vice President, Global Pharmacovigilance and Epidemiology, BRISTOL-MYERS SQUIBB
• Amrit Ray, MD, MBA, FCMI, Chief Safety Officer, Head, Global Medical Safety, JOHNSON & JOHNSON PHARMACEUTICALS GROUP
• Philippe Van der Auwera, MD, PhD, Global Head of Safety Risk Management (PDS) & EU-QPPV, Pharma Development, F.HOFFMANN-LA ROCHE LTD - Switzerland
• Mariette Boerstoel-Streefland, MD, MBA, MS(epi), Chief Safety Officer, Vice President, Global Drug Safety, FOREST RESEARCH INSTITUTE
• Juergen Schmider MD, PhD, Corporate Safety Officer and Vice President Global Pharmacovigilance & Epidemiology, CEPHALON, INC
• And many more – complete program information will soon be available at www.clinicaltrialpartnerships.com.

About Partnerships in Clinical Trials – Partnerships is the leading drug development event bringing clinical trials executives timely information and trends in sourcing models and successfully maintaining critical sponsor/provider relationships, as well as valuable best practices and networking for entire clinical teams. As the number one meeting place for clinical trial partners to gather under one roof, Partnerships in Clinical Trials is known for strategic program content that drives business forward and for unparalleled networking. Visit www.clinicaltrialpartnerships.com for more information.

To inquire about speaking, sponsoring or attending Partnerships in Clinical Trials, please contact Allison Rigels via email at ARigels@iirusa.com or phone at 646-895-7327.